Literature DB >> 15849515

Perianal Crohn disease: predictors of need for permanent diversion.

Susan Galandiuk1, Jennifer Kimberling, Talib G Al-Mishlab, Arnold J Stromberg.   

Abstract

OBJECTIVE: Fissures, fistulas, abscesses, and anal canal stenosis are manifestations of perianal Crohn disease (CD). There are no known predictors of which patients will fail sphincter-sparing surgical therapy and ultimately require fecal diversion.
METHODS: Of 356 consecutive patients with CD, 24% (86) had perianal CD (age range, 14-83 years), and women were slightly more frequently affected. Clinical variables were examined for factors predictive of the need for permanent fecal diversion.
RESULTS: CD associated with perianal CD was limited to the small bowel and/or ileocolic area in 23% of patients; the remainder had colorectal CD. Eighty-six patients underwent 344 operations. Forty-two patients (49%) ultimately required permanent diversion; among them were 21 of 32 patients (66%) with anal stricture and 12 of 20 women (60%) with rectovaginal fistula. Univariate analyses of clinical variables were performed with respect to need for permanent fecal diversion. Significant univariate predictors were the presence of colonic CD (P = 0.0045, odds ratio [OR] 5.4), avoidance of ileocolic resection (P = 0.0147, OR 0.4), and the presence of an anal stricture (P = 0.0165, OR 3.0). In multivariate logistic regression, the presence of colonic disease and anal canal stricture were predictors of permanent diversion. The OR associated with the risk of permanent diversion in the presence of colonic disease and in the absence of anal stricture was 10 (P = 0.0345). In the presence of both colonic disease and anal canal stenosis, the OR associated with permanent stoma was 33 (P = 0.0023).
CONCLUSIONS: The management of perianal CD continues to be challenging. Roughly half of patients required permanent fecal diversion, which was even more frequently true for patients with colonic CD and anal stenosis. Recognizing these tendencies will assist both patients and surgeons in planning optimal treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15849515      PMCID: PMC1357134          DOI: 10.1097/01.sla.0000161030.25860.c1

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Br J Surg       Date:  2000-12       Impact factor: 6.939

Review 2.  Diagnosis and treatment of perianal fistulas in Crohn disease.

Authors:  D A Schwartz; J H Pemberton; W J Sandborn
Journal:  Ann Intern Med       Date:  2001-11-20       Impact factor: 25.391

3.  Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap.

Authors:  Toyooki Sonoda; Tracy Hull; Marion R Piedmonte; Victor W Fazio
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

4.  Endorectal advancement flap: are there predictors of failure?

Authors:  Nelly Mizrahi; Steven D Wexner; Oded Zmora; Giovanna Da Silva; Jonathan Efron; Eric G Weiss; Anthony M Vernava; Juan J Nogueras
Journal:  Dis Colon Rectum       Date:  2002-12       Impact factor: 4.585

5.  The clinical course of fistulating Crohn's disease.

Authors:  S J Bell; A B Williams; P Wiesel; K Wilkinson; R C G Cohen; M A Kamm
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171

Review 6.  Etiology of the inflammatory bowel diseases.

Authors:  J P Hugot; H Zouali; S Lesage; G Thomas
Journal:  Int J Colorectal Dis       Date:  1999-02       Impact factor: 2.571

7.  Validation of a five-question survey to assess a child's exposure to environmental tobacco smoke.

Authors:  Jennifer A Seifert; Colleen A Ross; Jill M Norris
Journal:  Ann Epidemiol       Date:  2002-05       Impact factor: 3.797

Review 8.  Perianal Crohn's disease and infliximab therapy.

Authors:  D A McNamara; S Brophy; J M P Hyland
Journal:  Surgeon       Date:  2004-10       Impact factor: 2.392

9.  Perianal Crohn disease: a new scoring system to evaluate and predict outcome of surgical intervention.

Authors:  Alon J Pikarsky; Pascal Gervaz; Steven D Wexner
Journal:  Arch Surg       Date:  2002-07

10.  Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.

Authors:  Miguel Regueiro; Houssam Mardini
Journal:  Inflamm Bowel Dis       Date:  2003-03       Impact factor: 5.325

View more
  44 in total

Review 1.  Surgical management of Crohn's disease.

Authors:  Virginia Oliva Shaffer; Steven D Wexner
Journal:  Langenbecks Arch Surg       Date:  2012-02-21       Impact factor: 3.445

Review 2.  Recent trends in the surgical management of inflammatory bowel disease.

Authors:  Robert E Roses; John L Rombeau
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

3.  Perianal Crohn's disease.

Authors:  Bashar Safar; Dana Sands
Journal:  Clin Colon Rectal Surg       Date:  2007-11

4.  Management of nonhealing perineal wounds.

Authors:  Jill C Genua; David A Vivas
Journal:  Clin Colon Rectal Surg       Date:  2007-11

Review 5.  Surgery for inflammatory bowel disease.

Authors:  John M Hwang; Madhulika G Varma
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

6.  Impact of perineal Crohn's disease on utilization of care in the absence of modifiable predictors of treatment failure.

Authors:  Abdulmetin Dursun; Richard Hodin; Liliana Bordeianou
Journal:  Int J Colorectal Dis       Date:  2014-10-02       Impact factor: 2.571

Review 7.  Perianal Crohn's disease: is there something new?

Authors:  Cesare Ruffolo; Marilisa Citton; Marco Scarpa; Imerio Angriman; Marco Massani; Ezio Caratozzolo; Nicolò Bassi
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

8.  Sphincter-sparing intersphincteric rectal resection as an alternative to proctectomy in long-standing fistulizing and stenotic Crohn's proctitis?

Authors:  Nicolas Schlegel; Mia Kim; Joachim Reibetanz; Katica Krajinovic; Christoph-Thomas Germer; Christoph Isbert
Journal:  Int J Colorectal Dis       Date:  2015-04-08       Impact factor: 2.571

9.  Crohn's disease with anorectal stenosis successfully treated with vedolizumab.

Authors:  Darja Urlep; Rok Orel
Journal:  World J Pediatr       Date:  2017-08       Impact factor: 2.764

Review 10.  Surgical treatment of anorectal crohn disease.

Authors:  Robert T Lewis; Joshua I S Bleier
Journal:  Clin Colon Rectal Surg       Date:  2013-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.